J7505 Muromonab-cd3, parenteral, 5 mg

Short descriptor: Monoclonal antibodies

⚠ Terminated HCPCS Level II 2026
Terminated Code
J7505 was terminated as of 2025-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open J7505 in the app →

Look up J7505 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J7505 is the HCPCS Level II code for Muromonab-cd3, parenteral, 5 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2026-01-01
Termination Date
2025-12-31
2026 Maintenance
Discontinued

Drug Details

Drug / Substance
Muromonab-cd3, parenteral
Dose / Unit
5 mg

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J7505 with the canonical source and edition:

J7505 — Muromonab-cd3, parenteral, 5 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J7505

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J7505

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial